Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Oncology/Immunology528.62M63.08%
Other Ventures309.38M36.92%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
Research and Development (R&D) U.S. and Others345.96M41.28%
Other Ventures People's Republic of China309.38M36.92%
Marketed Products People's Republic of China157.02M18.74%
Research and Development (R&D) People's Republic of China18.49M2.21%
Marketed Products U.S. and Others7.15M0.85%
